Management of Blood Pressure Control: At the Cutting Edge

Chairpeople:

Bryan Williams,¹ Gianfranco Parati²

Speakers:

Thomas W. Weiss,³ Jean-Jacques Mourad,⁴ Massimo Volpe⁵

1. Institute of Cardiovascular Science, University College London, London, UK
2. St Luca Hospital, Istituto Auxologico Italiano, Milan, Italy
3. 3rd Medical Department, Wilhelminenhospital, Vienna, Austria
4. Avicenne University Hospital, AP-HP, Bobigny, France
5. University of Rome ‘La Sapienza’, Sant’Andrea Hospital, Rome, Italy

Disclosure:

Bryan Williams has received honoraria for lectures on hypertension from Daiichi Sankyo and  the Menarini Group. Gianfranco Parati has received honoraria for lecturing from Pfizer, Daiichi Sankyo, and Servier. Thomas W. Weiss has received lecture fees from AstraZeneca, Bayer, Boehringer Ingelheim,  Daiichi Sankyo, Eli Lilly, Medtronic, the Menarini Group, Novartis, Servier, and Vifor Pharma; advisory board and consultation fees from Abbot Vascular, AstraZeneca, Boston Scientific, Daiichi Sankyo, Eli Lilly,  Medtronic, and Sanofi Aventis; and research grants from AstraZeneca, the Austrian Science Fund, the  Austrian Cardiology Society, the Austrian Hypertension League, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, ISFP, the Menarini Group, and the Stein Erik Hagen Foundation. Jean-Jacques Mourad has received consultancy fees from Daiichi Sankyo, the Menarini Group, Servier, and Bristol-Myers Squibb. Massimo Volpe has received grants from the University of Rome Sapienza and the PRIN Italian Ministry of Health; has sat on speakers’ bureaux for Menarini International and Daiichi Sankyo Europe; and has acted  as a consultant and/or sat on advisory boards for Takeda International, Daiichi Sankyo Europe, Actelion,  and Novartis Pharma.

Acknowledgements:

Writing assistance was provided by Dr Lynda McEvoy of ApotheCom.

Support:

The symposium was jointly sponsored by Daiichi Sankyo and the Menarini Group. Authors  received honoraria for preparation and delivery of their presentations. The views and opinions expressed  are those of the authors and not necessarily of Daiichi Sankyo or the Menarini Group.

Citation:

EMJ Cardiol. 2015;3[Suppl 4]:10-17. DOI/10.33590/emjcardiol/10311935. https://doi.org/10.33590/emjcardiol/10311935.

Keywords:

European Society of Cardiology Congress

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.